|Publication type:||Article in scientific journal|
|Type of review:||Peer review (publication)|
|Title:||What is the threshold for a clinical minimally important drug effect?|
|Authors:||Hengartner, Michael Pascal|
|Published in:||BMJ Evidence-Based Medicine|
|Publisher / Ed. Institution:||BMJ Publishing Group|
|Subject (DDC):||615: Pharmacology and therapeutics |
616.8: Neurology, diseases of nervous system
|Fulltext version:||Published version|
|License (according to publishing contract):||Licence according to publishing contract|
|Organisational Unit:||Psychological Institute (PI)|
|Appears in collections:||Publikationen Angewandte Psychologie|
Files in This Item:
There are no files associated with this item.
Show full item record
Hengartner, M. P. (2018). What is the threshold for a clinical minimally important drug effect? BMJ Evidence-Based Medicine. https://doi.org/10.1136/bmjebm-2018-111056
Hengartner, M.P. (2018) ‘What is the threshold for a clinical minimally important drug effect?’, BMJ Evidence-Based Medicine [Preprint]. Available at: https://doi.org/10.1136/bmjebm-2018-111056.
M. P. Hengartner, “What is the threshold for a clinical minimally important drug effect?,” BMJ Evidence-Based Medicine, Aug. 2018, doi: 10.1136/bmjebm-2018-111056.
Hengartner, Michael Pascal. “What Is the Threshold for a Clinical Minimally Important Drug Effect?” BMJ Evidence-Based Medicine, Aug. 2018, https://doi.org/10.1136/bmjebm-2018-111056.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.